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Abstract (178 words)  
 Astrocytes are in control of metabolic homeostasis in the brain and support and 
modulate neuronal function in various ways. Astrocyte-derived L-lactate (LL) is thought to play 
a dual role as a metabolic and a signaling molecule in inter-cellular communication. The 
biological significance of LL release from astrocytes is poorly understood, largely because the 
tools to manipulate LL levels in vivo are limited. We therefore developed new viral vectors for 
astrocyte-specific expression of a mammalianised version of lactate oxidase (LOX) from 
Aerococcus viridans. LOX expression in astrocytes in vitro reduced their intracellular LL levels 
as well as the release of LL to the extracellular space. Selective expression of LOX in 
astrocytes of the dorsal hippocampus in mice resulted in increased locomotor activity in 
response to novel stimuli. Our findings suggest that a localised decreased intracellular LL pool 
in hippocampal astrocytes could contribute to greater responsiveness to environmental 
novelty. We expect that use of this molecular tool to chronically limit astrocytic LL release will 
significantly facilitate future studies into the roles and mechanisms of intercellular LL 












Lactate oxidase (LOX) expression limits the intra-astrocytic pool of lactate and decreases its 
release. 
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LOX in astrocytes of the dorsal mouse hippocampus causes increased activity in novel 
environment. 
 
Introduction (420 words) 
Astrocytes are the major regulators of brain metabolic homeostasis as they are able to 
import from the periphery, metabolize, store and dynamically shuttle energy substrates 
throughout the astrocytic network and into the brain’s extracellular space (Marina et al., 2020; 
Verkhratsky et al., 2015; Weber & Barros, 2015). At the same time, astrocytes, by responding 
to local neuronal activity and the extracellular environment, actively participate in synaptic 
transmission and inter-cellular communication (Gourine et al., 2010; Halassa et al., 2007; Lalo 
et al., 2014; Mastitskaya et al., 2020). Astrocyte-derived L-lactate (LL), in particular, has 
gained increasing attention due to its dual role as a metabolic and signaling molecule in the 
brain (Barros & Weber, 2018; Karagiannis et al., 2015; Magistretti & Allaman, 2018; Marina et 
al., 2018, 2020; Mosienko et al., 2015, 2018). 
During periods of increased local brain activity, astrocytes elevate their release of LL 
to support a wide range of brain area-dependent functions. Examples include promotion of 
learning and memory in hippocampus and cortex (Alberini et al., 2018; Newman et al., 2011; 
Yang et al., 2014; Zuend et al., 2020), cerebral angiogenesis (Morland et al., 2017), regulation 
of sympatho-excitation in the ventro-lateral medulla (Marina et al., 2015), improvement of 
decision making behavior by synchronisation of amygdala with anterior cingulate cortex 
(Wang et al., 2017), and amplification of the arousal response evoked by the locus coeruleus 
(Barros & Weber, 2018; Mosienko et al., 2018; Tang et al., 2014). LL is also known to modulate 
mood by as yet unknown mechanisms of action. Acute or chronic peripheral administration of 
LL in animal models of depression resulted in an antidepressant-like effect (Carrard et al., 
2018; Jouroukhin et al., 2018; Karnib et al., 2019). This response was accompanied by 
increased levels of LL in the hippocampus as well as changes in the expression of genes 
associated with serotonin receptor trafficking, the astrocytic calcium-binding protein S100β, 
neurogenesis and cAMP signalling (Carrard et al., 2018).  
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However, the mechanisms whereby LL influences metabolic and signalling pathways 
are poorly understood as the tools to manipulate LL levels in vivo in a cell type-specific manner 
are limited. With this in mind, we developed a novel viral vector system to express a 
mammalianized version of lactate oxidase (LOX) from Aerococcus viridans under control of  
an enhanced astrocyte-specific promoter (Liu et al., 2008). Expression of LOX in primary 
astrocytes reduced their intracellular LL pool and limited the release of LL. In comparison to 
control mice, mice selectively expressing LOX in astrocytes of the hippocampus demonstrated 
increased responsiveness to novel environmental stimuli.  
 
Materials and Methods (1762 words) 
Viral vector construction  
The sequence of Lactate oxidase (LOX; E.C. 1.1.3.15) from Aerococcus viridans 
(GenBank: D50611.1) was optimised for mammalian codon usage and synthesised by 
Invitrogen (Thermo Fisher Scientific UK). 
For functional testing in HEK293 cells, we constructed pCMV-LOX-IRES-EGFP, an 
expression vector with CMV promoter where the LOX open reading frame was inserted in 5’-
position of an internal ribosomal entry site (IRES), followed by green fluorescent protein 
(EGFP; Suppl Figure 1a). The equivalent cassette devoid of LOX served as control plasmid 
(pCMV-IRES-EGFP). Cells were transfected with TransIT-293 (Mirus, MIR 2700) 2-3 days 
prior to experiments. 
For in vitro tests in primary astrocytes, an adenoviral vector (AVV), AVV-sGFAP-LOX-
IRES-tdTomato (Suppl Figure 1b), was constructed by standard homologous recombination 
(Bett et al., 1994; Duale et al., 2005). In order to limit expression to astrocytes, we employed 
a transcriptionally enhanced shortened human GFAP promoter (sGFAP) (Liu et al., 2008). 
TdTomato was adopted as a reporter gene to avoid interference with the emission spectra of 
concomitantly used FRET sensor. Where indicated, AVV-sGFAP-EGFP was used as control.  
For gene delivery into astrocytes in vivo, the expression cassette was transferred  from 
AVV to  a lentiviral vector (LVV), LVV-sGFAP-LOX-IRES-tdTomato (Suppl Figure 1c) 
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(Coleman et al., 2003; Duale et al., 2005; Teschemacher et al., 2005). LVV-sGFAP-IRES-
tdTomato was created as a control vector. 
 
 Primary cultures  
Neonate Wistar rats were used in accordance with Schedule 1 of the UK Home Office 
(Scientific Procedures) Act (1986) and as approved by the University of Bristol ethics 
committees. Primary astrocytes were cultured following protocols adapted from (Marriott et 
al., 1995). Brains were dissected from Wistar P2 pups, and the coronal section including 
midbrain and brainstem was dissociated by trituration following incubation in Hank’s Balanced 
Salt Solution (HBSS) with DNase I (0.04 mg/mL), BSA (3 mg/mL), and bovine pancreas trypsin 
(0.25 mg/mL). Cells were incubated (37°C; 5% CO2) in culture media (Dulbecco′s Modified 
Eagle Medium, 10% heat-inactivated foetal bovine serum, 100 U/mL penicillin, 0.1 mg/mL 
streptomycin) for 7 days. Flasks were gently shaken overnight to eliminate microglia and 
oligodendrocytes and astrocytes were passaged. Following another 7 days in culture, AVVs 
were added to culture media 2-3 days prior to experiments to allow for optimal transgene 
expression.  
Preparation of organotypic slice cultures followed the previously described protocol 
(Teschemacher et al., 2005). The brainstem was isolated from P7-8 Wistar pups and 
transferred to sterile dissection medium containing HBSS, 20 mM glucose, 10 mM MgCl2, 1 
mM HEPES, 1 mM kynurenic acid, 0.5% phenol red, 100 U/mL penicillin and 0.1 mg/mL 
streptomycin (4°C). A vibrating microtome (7000 SMZ, Campden Instruments, Loughborough, 
UK) was used to cut 200μm-thick coronal slices. Slices were deposited on culture membranes 
(Millicell-CM, Millipore) in a six-well plates with media consisting of 49% Opti-MEM with 
GlutaMAX (Life Technologies, 51985026), 25% HBSS, 25% foetal bovine serum, 1% penicillin 
(10,000 units)/streptavidin(10 mL/L), 25mM glucose. Slices were transduced with ~109 TU/mL 
of AVV-sGFAP-LOX-IRES-tdTomato for expression of LOX specifically in astrocytes and kept 
at 37ºC and 5% CO2 for 8-12 days prior to experimentation.  
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Cell viability assays  
Primary astrocytes were exposed to a range of AVV-sGFAP-LOX-IRES-tdTomato 
titres, in order to determine the optimal multiplicity of infection (MOI) and avoid non-specific 
toxicity arising from overexpression in astrocytes. For the Trypan Blue exclusion assay, 
astrocytes were harvested by trypsinization and stained with trypan blue solution 0.4% (Sigma, 
T8154). The percentage of blue non-viable cells was determined. The XTT cell viability assay 
was performed according to the manufacturer’s instructions (Cell Signalling Technology, 
9095). The formazan absorbance after 2h, which is proportional to the number of metabolically 
viable cells, was read at 450 nm in a microplate reader (Tecan Infinite M200 PRO, Labtech).  
 
Measurements of extracellular L-lactate in vitro 
Constitutive release of LL into culture media was determined with a fluorometric assay 
(EnzyFluo L-Lactate Assay Kit, BioAssay Systems, EFLLC-100) following the manufacturer’s 
instructions. Media were exchanged and subsequently sampled after 2h for HEK293 and 6h 
for astrocytes. Following the enzymatic reaction, fluorescence was determined in the 
microplate reader with 530nm excitation at 585nm emission. The LL concentrations were 
determined according to the LL standard curve. 
Real-time measurement of LL release in organotypic slices was performed using 
amperometric LL biosensors (Sarissa Biomedical, UK, SBS-LAC-05-50, SBI-NUL-05-50). 
Sensors were calibrated by applying defined concentrations of LL to the chamber before and 
after each recording. Slices were transferred to the recording chamber and continuously 
superfused with HEPES-buffered solution (HBS; in mM: NaCl 137, KCl 5.4 or 3, Na2HPO4 
0.34, KH2PO4 0.44, CaCl2 1.6, MgSO4 0.8, NaHCO3 4.2, HEPES 10, Glucose 5.5; pH 7.4)  at 
2.5 ml/min (32.5 ± 1ºC). The electrode potential was controlled by a potentiostat (Duo-Stat 
ME200+) and the signal was processed and analysed using a 1401 interface and Spike 2 
software (Cambridge Electronic Design, UK). Electrodes were brought to contact with the slice 
surface and left to stabilise for at least 30 min. Sensors were then moved to a different area 
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of the slide and allowed to plateau following the initial contact, before measurements of the 
constitutive release (LL tone) were taken.  
For forced LL efflux from the cells, a trans-acceleration protocol was employed by delivering 
10mM pyruvate to the recording chamber (Mächler et al., 2016; San Martín et al., 2013; Zuend 
et al., 2020). This approach  relies on the inward gradient of the monocarboxylate transporter 
(MCT) substrate pyruvate to trigger MCT-mediated LL extrusion from the cells (Fishbein et al., 
1988). 
 
Assessing intracellular L-lactate in vitro  
Primary cultures of astrocytes on collagenised glass coverslips were transduced with an AVV 
to express the LL FRET sensor Laconic (San Martín et al., 2013) and co-transduced with AVV-
sGFAP-LOX-IRES-tdTomato. Coverslips were transferred to a recording chamber mounted 
on an upright Leica confocal microscope (SP1 or SP5) and continuously superfused with HBS 
(glucose 2mM) at 2.5 ml/min (32.5 ± 1ºC). Laconic was excited with 458nm and emission 
bands for mTFP and Venus were sampled every 3 seconds for 465-500nm and 515-595nm 
bands, respectively. Regions of interest were analysed for the mTFP/Venus FRET ratio over 
time and average changes after pyruvate application were normalised to the baseline. 
 
In vivo experiments  
Animals and Surgical procedures 
C57Bl/6J mice (female, 8 weeks of age) were obtained from Jackson Lab and housed in 
groups of 3-5 animals in standard mouse cages on a 12-h light/dark cycle at a room 
temperature of 23°C with free access to food and water. The animal protocols were carried 
out in accordance with the Johns Hopkins University Animal Care and Use Committee. All 
experiments were performed during the light half of the cycle. Procedures were conducted 
using aseptic techniques. Mice were anesthetized with a 0.75% - 1% isoflurane-oxygen 
mixture (2% for induction) and placed in a supine position on a heating pad connected to a 
rectal thermometer (∼37°C). For the dorsal hippocampus, 0.5 µL of LVV-sGFAP-IRES-
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tdTomato (control; 5x109 TU/mL) or LVV-sGFAP-LOX-IRES-tdTomato (7x109 TU/mL) were 
injected bilaterally into the dorsal CA1 area of the hippocampus (AP, ML, DV: -1.9 mm; ±1.4 
mm; -1.6 mm) at 1 nL/sec using Nanoject III (Drummond Scientific Company, Broomall, PA), 
as previously described (Jouroukhin et al., 2019). After the injection, we waited 10 minutes 
before raising the glass micropipette. After surgery, mice were treated with buprenorphine 
(0.01 mg/kg s.c.) and Baytril (enrofloxacin, 2.5 mg/kg). 
 
Behavioral tests 
Mice were tested 4 weeks following surgery in a series of behavioural tests to assess 
novelty-induced activity in the open field, anxiety in the elevated plus maze (EPM), and 
exploratory activity in the hole board test.  For the hole board test, the mice were placed in the 
center of a 40cm x 40cm hole board enclosure, with 16 three-centimeter holes spaced evenly 
(Stoelting Co., Illinois, USA). Mice were allowed to explore the hole board for 5 minutes. 
Distance travelled and head dips were recorded using Any-maze tracking software (Stoelting, 
Co.). These tests were followed by those for learning and memory: spontaneous alternation 
and  spatial recognition in the Y maze, the novel object recognition test (NORT) and novel 
place recognition test (NPRT) and trace fear conditioning as previously described in  (Abazyan 
et al., 2010, 2014; Pletnikov et al., 2008; Jouroukhin et al., 2018; Terrillion et al., 2017). All 
tests were conducted in the order that minimized potential carry-over effects and stressful 
experience confounds, namely, with a one-week interval between tests and from less to more 
stressful tests.  
 
Immunohistochemistry  
Transgene expression in primary cultured astrocytes and organotypic brainstem slices 
was confirmed by immunoreactivity to red fluorescent protein (RFP). Cells were fixed with ice-
cold 4%paraformaldehyde (PFA) in 0.1 M phosphate buffer (PBS; pH 7.4), rinsed with PBS 
and incubated in a blocking and permeabilizing solution for 1 hour at room temperature (RT), 
followed by incubation with the anti-RFP primary antibody (1:200, Suppl Table 1) overnight at 
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4°C. An Alexa Fluor 594-labeled species-specific secondary antibody was used. Images were 
obtained with an upright Leica SP5 confocal laser-scanning microscope with 25x or 40x water 
immersion objective lenses.   
Upon completion of behavioural tests, mice were deeply anesthetized with Forane 
(isoflurane USP, NDC 10019-360-60, Baxter Healthcare Corporation, Deerfield, IL, USA), 
followed by transcardial perfusion with ice-cold 0.1 M PBS and 4% PFA in 0.1 M PBS. The 
brains were dissected out and post-fixed in 4% PFA in 0.1 M PBS for 24h at 4ºC. After 
cryoprotection in 30% sucrose in 0.1 M PBS for 48 h, the brains were cut into 40 µm thick 
coronal sections.  
The transduced brain areas were identified by their expression of tdTomato. To 
evaluate the brain cell types that were transduced with LVV, brain sections were stained with 
chicken anti-GFAP (1:1000), rabbit anti-S100 beta (1:1000), rabbit anti-Iba1 (1:1000) or 
Guinea pig anti-NeuN (1:1000) antibodies as previously described (Hoffman et al., 2016; 
Jouroukhin et al., 2019). Briefly, after incubating brain sections in the blocking solution for 1 h 
at RT, the sections were incubated for 48 hours at 4°C with the primary antibodies. Afterwards, 
the sections were incubated for 2 hours at RT with the corresponding Alexa 488-, 568-, 633-
labeled species-specific secondary antibodies (1:1000) followed by three 5-min 3xPBS 
washes and DAPI 10 min staining (1:10000). Images were taken with a Zeiss 880 confocal 
laser-scanning microscope with 40x/1.3 oil DIC or 100x/1.46 oil DIC objectives at the Johns 
Hopkins University Neuroscience Multiphoton/Electrophysiology Core Facility. 
  
Statistical Analysis  
Data were subjected to a Shapiro–Wilk normality test. Groups were compared using 
paired or unpaired two-tails t-tests, ANOVA followed by Bonferroni's Multiple Comparison post 
hoc test, or non-parametric Wilcoxon-Mann–Whitney U test, as indicated. Box-and-whisker 
diagrams illustrate the upper and lower quartile values (boxes), median (central horizontal 
line), mean (central plus sign), and minimum and maximum data range (whiskers). Statistical 
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tests were performed using GraphPad Prism. Statistical difference of p<0.05 between the 
experimental groups was considered significant.  
 
Results (642 words) 
In vitro effects of LOX expression  
Astrocytes transduced with AVV-sGFAP-LOX-IRES-tdTomato at MOI 15 in dissociated 
primary cultures and with 109 TU/mL in organotypic slices displayed typical in vitro morphology 
and their survival was not compromised compared to un-transduced cultures (Suppl Figure 
2b,c). A range of MOIs of AVV-sGFAP-LOX-IRES-tdTomato was used to transduce cultures, 
and their viability was assessed by Trypan Blue exclusion assay and XTT assay. In neither 
assay did control vector AVV-sGFAP-EGFP compromise the viability of astrocytes below an 
MOI of 50 (Figure 1). Therefore, all the functional validation experiments were carried out at 
MOI 15. 
 
LOX expression reduces constitutive L-lactate release in vitro 
The effect of LOX expression on release of LL was assessed in HEK293 cells and in primary 
astrocytes. Expression of a reporter fluorophore confirmed that the majority of cells were 
expressing the transgenes (Suppl Figure 2a,b). Concentration of LL in the conditioned 
extracellular media was significantly decreased by LOX (33.2% in HEK293 cells and 15.4% in 
astrocytes), reflecting limited constitutive LL release (Figure 2a,b). In line with this, 
amperometric recordings revealed that expression of LOX by astrocytes in organotypic slices 
significantly decreased LL tone when compared to control slices (Figure 2c).  
 
LOX expression reduces the intracellular L-lactate pool in vitro 
The change in intracellular LL was measured with confocal Laconic imaging while forcing LL 
depletion via pyruvate-evoked trans-acceleration (Mächler et al., 2016; San Martín et al., 2013; 
Zuend et al., 2020). As expected, bath application of pyruvate (10mM) evoked a substantial 
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drop in the intracellular concentration of LL in cultured dissociated astrocytes which was 
significantly decreased in LOX-expressing cultures (Figure 2d,e).  
Trans-acceleration in cultured brainstem slices evoked an immediate and distinct peak in the 
extracellular concentration of LL in all slices (Figure 2f). The net amplitude of trans-
acceleration-driven LL release was significantly reduced by 65.8% in slices transduced with 
AVV-sGFAP-LOX-IRES-tdTomato (Figure 2g). Pyruvate-driven LL release was followed by a 
transient decrease in LL concentration (depletion amplitude; Figure 2f) which is thought to 
reflect the depletion of the readily available intracellular LL pool that normally overflows as 
constitutive release. The drop from baseline LL to the following minimum LL release was 
reduced by 78.5% in slice cultures containing LOX-expressing astrocytes, suggesting, again, 
a diminished intra-astrocytic LL pool (Figure 2h). 
 
In vivo effects of LOX expression in astrocytes of dorsal hippocampus 
 Analysis of expression of tdTomato indicated that LVV-sGFAP-LOX-IRES-tdTomato 
transduced astrocytes within a limited area of the dorsal hippocampus (Figure 3a). Using the 
anti-RFP antibody, we observed a wider spread of transgene expression (Figure 3b). 
Expression driven by this LVV was selective for astrocytes as no positive staining was seen 
in neurones or microglia (Suppl Figures 3-4).   
 Expression of LOX in hippocampal astrocytes did not alter general activity of mice in 
the open field test, including central, peripheral or rearing activities (Suppl Figure 5). No effects 
of LOX expression were observed on anxiety-like behaviour in the EPM (Suppl Figure 6). 
Compared to control mice, mice expressing LOX in astrocytes exhibited a significantly 
increased locomotor activity in the hole board test without altering number of head dips, 
suggesting elevated novelty-induced activity (Figure 3c, Suppl Figure 6). In addition, mice 
expressing LOX showed significantly less freezing behaviour during the habituation session 
in the trace fear conditioning test, indicative of elevated reactivity to unfamiliar environment 
(Figure 3d). When we assessed the effects of LOX on learning and memory, no significant 
changes were seen in spontaneous alterations in the Y maze test, the novel object recognition 
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test or the context- or cue-dependent conditional freezing  in the trace fear conditioning test 
(Figure 3f,g; Suppl Figure 7). In contrast, compared to control mice, mice expressing LOX 
demonstrated a superior spatial recognition memory in the Y maze (Figure 3e). Collectively, 
our findings suggest that expression of LOX in hippocampal astrocytes led to increased 
responsiveness to novelty in mice that could facilitate some types of recognition memory. 
 
Discussion (795 words) 
The release of LL in the brain is not only dependent on its production rate but 
astrocytes have the ability to retain higher intracellular LL levels as a readily releasable pool 
which is available for stimulus-evoked transient release (Mächler et al., 2016; Sotelo-
Hitschfeld et al., 2015). Here we report the validation and application of a novel viral vector-
based molecular approach, designed to limit the intra-astrocytic LL pool without directly 
interfering with astrocytic LL production or release mechanisms (Figure 4). We have confirmed 
in vitro that LOX is enzymatically active and changes LL dynamics in dissociated cultured 
astrocytes and organotypic brainstem slices. Astrocyte-specific expression of LOX reduced 
the constitutive release of LL, as well as that evoked using a trans-acceleration protocol. 
Although trans-acceleration of MCTs has been recurrently used in vitro and in vivo to deplete 
cells of LL, this effect comes at the expense of cellular overload with pyruvate, which could 
result in LDH-mediated conversion of pyruvate to LL, increasing cytosolic LL concentration. In 
order to restrict LL formation following pyruvate application, the glucose concentration in the 
superfusion buffer was reduced so that the generation of NADH through glycolysis was limited 
and, with it, the activity of lactate dehydrogenase (San Martín et al., 2013). We found that 
trans-accelerated LL extrusion was substantially decreased in organotypic brainstem slices 
that contained both neurones and astrocytes. However, as LOX expression was targeted to 
astrocytes, our findings suggest that limiting the LL pool selectively in astrocytes makes a 
significant impact on LL dynamics in the integrated brain environment.  
The degradation of LL to pyruvate by LOX results in production of hydrogen peroxide 
(Maeda-Yorita et al., 1995; Stoisser et al., 2016) (Figure 4). Whilst peroxide is a potentially 
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harmful molecule, astrocytes have been shown to exhibit a high glutathione content and a 
robust capacity for glutathione-dependent detoxification  (Dringen et al., 2015; Liu et al., 2017). 
In order to minimize the potentially cytotoxic effects of ROS-mediated cellular damage or 
overexpression of a foreign protein product on astrocytic metabolism, we optimised vector 
titers to express LOX at the levels that did not seem to lead to any untoward consequences. 
Our in vivo observation do not suggest overt toxic effects on astrocytes either but future 
studies will perform a more detailed evaluation of possible ROS-mediated cellular effects of 
LOX expression.  
The behavioural effects of astrocyte-restricted expression of LOX in the dorsal 
hippocampus suggest that decreased release of LL by hippocampal astrocytes increased 
responsiveness to novelty and did not affect anxiety in mice. These changes are consistent 
with the different functions of the dorsal vs. ventral hippocampus. It has been shown that the 
processing of novelty and spatial information is predominantly associated with the dorsal sub-
regions of the hippocampus, while emotionality and anxiety have been preferentially attributed 
to the ventral areas of the hippocampus (Bannerman et al., 2014). This also concords with 
studies showing that peripheral LL administration did not alter baseline anxiety in rodents 
(Karnib et al., 2019).  
Our behavioural results are consistent with numerous findings from humans, 
nonhuman primates, and rodents that the hippocampus plays the central role in the novelty 
detection, and the activity of the hippocampal circuits increases in response to novel stimuli 
(Murty et al., 2013). On the one hand, increased activity in the hole board test is in line with 
increased exploratory activity in LOX expressing animals. On the other hand, as LOX 
expression led to low freezing during the habituation stage in TFC, one could propose that 
decreased LL release by hippocampal astrocytes might affect habituation to the novel 
environment in mice. Notably, a recent study reports that selective chemogenetic activation of 
striatal astrocytes produced “acute behavioural hyperactivity and disrupted attention” and that 
thrombospodin-1 in astrocytes was required for manifestation of the behavioural phenomena 
(Nagai et al., 2019). It is tempting to speculate that our findings point to another possible 
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pathway that could be at play in the neuron-astrocyte interactions underlying the higher 
functions of the hippocampus. Further, one could hypothesize that given the short period of 
time during which the mice were behaviourally evaluated, our data suggest a signalling rather 
than metabolic role for LL in the tests used. Future studies using viral vector mediated LOX 
expression will help shed more light on the mechanisms and processes whereby astrocyte LL 
is involved in inter-cellular communications in the brain.  
In conclusion, astrocyte-specific expression of LOX to limit intracellular LL pools 
represents a novel approach to elucidate the functions of LL in different brain cells. This 
approach allows for manipulating LL dynamics in chronic studies to elucidate the roles of LL 
in intercellular signalling and/or energy metabolism. We anticipate that the present study will 
facilitate a more accurate and nuanced understanding of how astrocytic LL contributes to the 
central networks in various physiological and pathological contexts (Figure 4). 
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Figure 1. In vitro viability of AVV-transduced cultured astrocytes expressing LOX or a 
control reporter. Trypan Blue exclusion assay (a) and XTT assay (b) consistently reported 
no effect of AVV-sGFAP-LOX-IRES-tdTomato on cell viability below an AVV MOI of 50; cell 
viability was unaffected by transduction with reporter (EGFP) expressing control AVV across 
the range of tested MOI ratios. (a) Sample sizes n=8 wells in No AVV, n=5 and n=6 wells in 
Control MOI 15 and 50, respectively, and n=6 and n=5 wells in LOX MOI 15 and MOI 50, 
respectively. (b) Sample sizes n=6 wells in no AVV, and n=9 wells in Control and LOX at all 
MOIs tested. ANOVA (Bonferroni's Multiple Comparison Test) for comparison between control 
AVV transduction and un-transduced astrocytes; unpaired two-tailed t-test for comparison of 
LOX to control reporter expressing astrocytes at each MOI tested.  
 
Figure 2. LOX expression reduces LL release in vitro. (a) Media conditioned for 2 hours 
by HEK293 cells transfected with 1µg/µl of either pCMV-IRES-EGFP (Control, n=6 wells) or 
pCMV-LOX-IRES-EGFP (LOX, n=9 wells; unpaired two-tailed t-test). (b) Media conditioned 
for 6 hours by dissociated cultured astrocytes transduced with AVV-sGFAP-EGFP (Control, 
n=18 wells) or AVV-sGFAP-LOX-IRES-tdTomato (LOX, n=9 wells; unpaired two-tailed t-test). 
(c) Amperometric measurement of extracellular LL tone in organotypic brainstem slices 
transduced with AVV-PRSx8EGFP alone (Control, n=14) or in combination with AVV-sGFAP-
LOX-IRES-tdTomato (LOX, n=12; Mann–Whitney U rank test). (d) Representative traces of 
Laconic FRET ratio in dissociated astrocytic cultures expressing AVV-CMV-Laconic alone 
(Control) or in combination with AVV-sGFAP-LOX-IRES-tdTomato and exposed to pyruvate 
(10mM; highlighted application time). (e) Minimum Laconic FRET ratios in control and LOX-
expressing astrocytes evoked by extrusion of intracellular LL via transacceleration of MCTs 
(n=62 cells in Control; n=52 cells in LOX; unpaired two-tailed t-test). (f) Representative trace 
of an amperometric recording in organotypic brainstem slices during pyruvate-induced 
transacceleration. (g) Trans-acceleration and (h) depletion amplitude, respectively, following 
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pyruvate (10mM) exposure in slices transduced with AVV-PRSx8EGFP alone (Control, n=11) 
or in combination with AVV-sGFAP-LOX-IRES-tdTomato (LOX, n=12); unpaired two-tailed t-
test (g) or Mann–Whitney U rank test (h). 
 
Figure 3. Expression of LOX in hippocampal astrocytes leads to novelty-induced 
activity. (a) Serial coronal sections of the mouse brain with control vector (LVV-sGFAP-IRES-
tdTomato) injection in the hippocampus and stained with anti-RFP (green); scale bars 500 μm. 
(b) Representative images of hippocampal sections with tdTomato+ astrocytes (red) co-
stained with anti-RFP (green); scale bars – 50μm. (c) In the holeboard test mice expressing 
LOX in hippocampal astrocytes manifested increased activity compared to control LVV 
injected mice; (d) During habituation to the trace fear conditioning chamber, mice expressing 
LOX in hippocampal astrocytes showed less freezing in response to a novel environment; 
*p<0.05, n=8-9. (e) Hippocampal LVV-sGFAP-LOX-IRES-tdTomato injections improved the 
performance in the task for spatial recognition memory in the Y maze task (a), with no change 
in the y-maze spontaneous alternation task (f) or the novel object recognition test (g); 
**p<0.01, n=5-9. 
 
Figure 4. Viral vector mediated expression of LOX in astrocytes as a novel tool for 
accelerated breakdown of intracellular LL. Constitutive activity of LOX breaks down LL 
produced through glycolysis in astrocytes and, consequently, decreases intra-astrocytic LL 
concentration and subsequent release to the extracellular space. This has implications for 
constitutive as well as stimulus-evoked LL release and for metabolic and signalling roles of LL 




Supplemental Figure Legends 
 
Suppl Figure 1. Cassette for expression of LOX in cell lines and in astrocytes in vitro 
and in vivo. (a) LOX and control constructs in plasmids for CMV-driven expression in acutely 
transfected HEK293 cells – CMV-LOX-IRES-EGFP and CMV-IRES-EGFP, respectively. 
Enhanced green fluorescent protein (EGFP) serves as expression marker and is preceded by 
an internal ribosomal entry site (IRES). (b) Construct in adenoviral vector (AVV) backbone for 
expression of LOX and fluorescent marker in astrocytes in vitro – AVV-sGFAP-LOX-IRES-
tdTomato. A transcriptionally enhanced short glial fibrillary acidic protein promoter (sGFAP; 
Liu et al., 2008) restricts expression to astrocytes. tdTomato was used as fluorescent marker. 
(c) Cassettes in lentiviral vector (LVV) backbone for expression of LOX and control fluorescent 
marker in astrocytes in vivo (Duale et al., 2005) – LVV-sGFAP-LOX-IRES-tdTomato and LVV-
sGFAP-IRES-tdTomato, respectively. A Woodchuck Hepatitis Virus posttranscriptional 
regulatory element (WPRE) was included to stabilise expression levels. 
 
Suppl Figure 2. Representative images of co-expression of fluorescent reporters with 
LOX in vitro. (a) EGFP expression in CMV-LOX-IRES-EGFP transfected HEK293 cells. (b) 
Dissociated cultures of rat astrocytes transduced with AVV-sGFAP-LOX-IRES-tdTomato. (c) 
Organotypic brainstem slice cultures transduced with AVV-sGFAP-LOX-IRES-tdTomato. 
tdTomato signal amplified by anti-RFP staining in (b) and (c). Scale bars 50 µm. 
 
Suppl Figure 3. Astrocyte specific expression in hippocampus in vivo following 
transduction with LVV-sGFAP-LOX-IRES-tdTomato. (a) Representative images of 
tdTomato+ (red) astrocytes co-stained with anti-S100β (green) antibody. (b) Representative 




Suppl Figure 4. Lack of neuronal and microglial expression in vivo following 
transduction with LVV-sGFAP-LOX-IRES-tdTomato. Representative images of tdTomato+ 
(red) astrocytes co-stained with anti-IBA1 (green) or anti-NeuN (magenta) antibody. Scale bar 
10μm. 
 
Suppl Figure 5. No effects of LOX expression in hippocampal astrocytes on locomotor 
activity. Locomotor activity was measured during 30 minutes in the open field. Total activity 
(a), total rearing (b), central (c) and peripheral (d) locomotor activities were not different 
between animals expressing LOX and controls; p>0.05, n=8-9. 
 
Suppl Figure 6. No effects of LOX expression in hippocampal astrocytes on anxiety-
related or exploratory behaviours. Anxiety-like behaviors were evaluated in the elevated 
plus maze (EPM). There was no difference in percent of time spent in the open arms (a) and 
the distance travelled (b) between control and LOX groups. (c) Exploratory behavior was 
examined in in the holeboard test. There was no significant difference in the number of head 
dips between control and LOX groups. p > 0.05, n=8-9.  
 
Suppl Figure 7. No effects of LOX expression in hippocampal astrocytes on trace fear 
conditioning. (a) No difference in freezing behaviour was found between control and LOX 
groups during the training session, where a 20 sec tone, followed by a 2 sec shock, was 
delivered four times as indicated. No difference was observed 24 hours after the training 






















































































































































































































































































































Primary Antibody for Immunohistochemistry Species Dilution Source Cat #
Anti-Glial Fibrillary Acidic Protein (GFAP) chicken polyclonal antibody 
mixture
chicken 1:1000 Aveslab GFAP
Anti-Iba1 Antibody rabbit 1:1000 Wako Chemicals 019-19741
Anti-NeuN Antibody guinea pig 1:1000 Synaptic Systems 266 004
Anti- RFP Antibody Pre-adsorbed rabbit
1:1000
1:200
Rockland Immunochemicals, Inc. 600-401-379S
Anti-S100 beta Antibody rabbit 1:1000 Abcam EP1576Y
Secondary Antibody for Immunohistochemistry Species Dilution Source Cat #
Goat anti-Rabbit IgG (H+L) Cross-Adsorbed 
ReadyProbes™ Secondary Antibody, Alexa
Fluor 594
goat n/a Thermo Fisher Scientific R37117
Goat anti-Guinea Pig IgG (H+L) Highly Cross-
Adsorbed Secondary Antibody, Alexa Fluor 633
goat 1:1000 Thermo Fisher Scientific A-21105
Goat anti-Rabbit IgG (H+L) Highly Cross-
Adsorbed Secondary Antibody, Alexa Fluor 488
goat 1:1000 Thermo Fisher Scientific A-11075
Goat anti-Chicken IgY (H+L) Secondary Antibody, Alexa Fluor 488 goat 1:1000 Thermo Fisher Scientific A-11039
Suppl Table 1. Antibody information
IRESLOX EGFPCMV
IRES EGFPCMV
IRESLOXGAL4p65AVV mCMV GfaABC1D WPREtdTomato
IRESLOXGAL4p65LVV mCMV GfaABC1D WPREtdTomato
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Suppl Figure 3. 
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Suppl Figure 7. 
